✦ LIBER ✦

A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?

✍ Scribed by Nicoletta Staropoli, Domenico Ciliberto, Cirino Botta…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-minimisation analysis of pegylated

✍ Ojeda, B; de Sande, L M; Casado, A; Merino, P; Casado, M A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

8028 Safety analysis of trabectedin in c

✍ Vergote, I.; Vermorken, J.; Pujade-Lauraine, E.; Monk, B.; Lisyanskaya, A.; Rols 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Carboplatin and pegylated liposomal doxo

✍ Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 124 KB

Effect of BRCA1 and XPG mutations on tre

✍ Monk, B.J.; Ghatage, P.; Parekh, T.; Henitz, E.; Knoblauch, R.; Soto Matos-Pita, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

T1506: Do We Still Need Endoscopic Ultra

✍ Roos E. Pouw; Noor Heldoorn; Lorenza Alvarez Herrero; Fiebo J. Ten Kate; Mark I. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 119 KB

8050 POSTER Cost-effectiveness of Trabec

✍ Gore, M.; Vergote, I.; Vasanthan, S.; Chan, S.; Arranz, J.M.; Colombo, N.; Arran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB